Trial results lead to new treatment option for lung cancer

promising pre-clinical data on preventing cytokine release syndrome

Phase 3 trial indicates significant efficacy and safety for children and adolescents

New antibody therapy shows promise in managing condition

Versant Ventures leads investment round to advance drug

Data highlights effectiveness of EVER001 in treating pMN

Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for […]

Partnership aims to develop new radiopharmaceuticals for cancer treatment

New SureSeq CLL + CNV V3 panel improves understanding of CLL

Race to create first oral drug for obesity intensifies